a:head bio AG Company Profile, Contacts & Intelligence

a:head bio AG Overview

a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement. The technology has been pioneered by the company’s co-founders Madeline Lancaster and Juergen Knoblich and is exclusively licensed to a:head by the Institute of Molecular Biotechnology, Vienna, Austria. a:head applies these complex 3D tissue cultures for modelling of various brain disorders in a human context and aims at translating the technology into a powerful high content, high throughput phenotyping platform for the development of novel CNS therapeutics.

Headquarters

Vienna, At

Website

aheadbio.com

Industry

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

a:head bio AG Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

a:head bio AG People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

a:head bio AG Workforce Composition

Seniority breakdown across 7 visible profiles.

a:head bio AG Technology & Talent

Technology-related job titles represented in the visible people data.

Compare Similar Companies to a:head bio AG

Explore companies in related markets and compare their industry and employee estimates.